Lung Cancer Journal Articles

• Circulating Serotonin Levels in COPD Patients What can the levels of circulating serotonin tell us about the pathogenesis of COPD?
  BMC Pulmonary Medicine, January 2019
• High-Dose Chemo and Stem-Cell Rescue for Ewing Sarcoma Consolidation high-dose chemotherapy with busulfan and melphalan may better survival in patients with Ewing sarcoma at high risk for relapse.
  Journal of Clinical Oncology, January 2019
• Next-Generation Sequencing Tests to Guide Cancer Treatment A survey finds that oncologists use NGS tests to guide decisions on management of refractory disease, eligibility for clinical trials, and off-label use of drugs.
  JCO Precision Oncology, January 2019
• Cerebellar Large B-cell Lymphoma: A Case Report This case report reviews the diagnosis, pathophysiology and management of primary central nervous system lymphoma, an aggressive non-Hodgkin lymphoma.
  Journal of Medical Case Reports, January 2019
• Effect Sizes of Somatic Mutations in Cancer Determination of cancer effect size may be immediately useful for precision medicine tumor boards, design of clinical trials, and drug development.
  Journal of the National Cancer Institute, January 2019
• QoL Deterioration in IPF Patients in the Last Years of Life A new study finds that IPF patients may experience significantly reduced quality of life in the two years before death, highlighting the need for palliative and end-of-life care for these patients.
  BMC Pulmonary Medicine, January 2019
• Trends in End of Life for Patients With Stage IV Lung Cancer Do patients with stage IV lung cancer often require care in the ICU during terminal hospitalizations?
  Journal of Oncology Practice, January 2019
• Exposure to Secondhand Smoke Among Nonsmokers: US, 1988-2014 This report shows that secondhand smoke exposure among U.S. nonsmokers has decreased considerably during the past two and a half decades, but progress has stalled in recent years.
  Morbidity & Mortality Weekly Report, January 2019
• Chemotherapy Strategies in Malignant Pleural Mesothelioma Is immunotherapy beneficial in patients with progressive malignant pleural mesothelioma after initial platinum-based chemotherapy?
  Translational Lung Cancer Research, December 2018
• Therapy for Hepatocellular Carcinoma: Beyond Sorafenib Immunotherapy and protein kinase inhibitors show promise for the treatment of advanced HCC.
  Chinese Clinical Oncology, December 2018
• Quality of Life Needs in Older Patients With Cancer A position paper from the International Society of Geriatric Oncology recommends that clinicians place a greater focus on the quality of life of older adults living with cancer.
  Annals of Oncology, December 2018
• Alectinib-induced Reversible Grade IV Nephrotoxicity This case underscores the potential of the tyrosine kinase inhibitor alectinib to cause severe grade 4 renal toxicity, which was reversible in this patient with metastatic lung cancer.
  Journal of Medical Case Reports, December 2018
• Tumor Mutation Burden as a Biomarker in Resected NSCLC Use of tumor mutation burden may help identify patients who can achieve a more pronounced survival benefit from adjuvant chemotherapy for NSCLC.
  Journal of Clinical Oncology, December 2018
• Ribociclib for Advanced HR+ Breast Cancer The combination of ribociclib, a CDK 4/6 inhibitor, and letrozole may be used successfully in a broad population of patients with advanced HR+/HER2- breast cancer.
  Breast Cancer Research, December 2018
• Navigating Systemic Therapy in Advanced Thyroid Carcinoma Find out more about the available treatment options for advanced cases of thyroid cancer.
  Journal of the Endocrine Society, December 2018
• Inherited Lung Cancer Syndromes Targeting Never Smokers Which germline mutations are associated with inherited lung cancer syndromes in never smokers?
  Translational Lung Cancer Research, November 2018
• Drug-Induced Uveitis Which medications may be associated with the development of uveitis?
  Current Opinion in Ophthalmology, November 2018
• Next Frontiers in Systemic Therapy for Soft Tissue Sarcoma Molecularly targeted therapy and immunotherapy are changing the treatment landscape of soft tissue sarcoma.
  Chinese Clinical Oncology, November 2018
• An Unsuspected Complication With Immune Checkpoint Blockade This rare occurrence of immune-related hyperthyroidism emphasizes the importance of the differential diagnosis when dealing with patients on immune checkpoint inhibitors.
  Journal of Medical Case Reports, November 2018
• Targeted Therapy to Resensitize Tumors to Radioactive Iodine How might targeted therapy help patients with advanced thyroid cancer that has become radioactive iodine refractory?
  Journal of Clinical Endocrinology & Metabolism, November 2018